Phase 1/2 Trial of AEF0217 in Participants With Down Syndrome

NCT05748405 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Down Syndrome

Interventions

DRUG: Placebo
DRUG: AEF0217

Sponsor

Aelis Farma

Collaborators

[object Object]